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Abstract Antimicrobial peptides are promising anti-cancer
agents with a unique mode of action. We established the
usage of a chip-based sensor to monitor the dynamic
interplay between cells on the chip and peptides and
compared it with endpoint tests. Human neuroblastoma
cancer cells and spontaneously immortalized non-cancer
keratinocytes were perfused with representative peptides
(NK-2, NK11, and melittin). The sensor system enabled
continuous recording of cell layer impedance (adhesion/
confluence), oxygen consumption (respiration) and extra-
cellular acidification (glycolysis) and provided insights in
cell damage, stress response and recovery. Cells responded
differentially to peptide treatment. During perfusion, pep-
tides accumulated on the cell surface until they reached a
critical concentration. Preceding to cell death, melittin
triggered glycolysis, suggesting stress response. NK-2
induced no change in energy metabolism, but led to an
increase in impedance, i.e. a temporarily altered morphol-
ogy, which appeared to be an excellent parameter to detect
subtle structural changes of cell layers.
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Most of the commonly used chemotherapeutics for the
treatment of cancer are also harmful to healthy human cells.
Consequently, patients undergoing chemotherapy usually
suffer from detrimental side effects (Stortecky and Suter
2010). Furthermore, cancer cells develop multi-drug resis-
tance (MDR) proteins to expel the drugs from the cell
(Andjelkovic et al. 2008). As a promising alternative, so-
called antimicrobial peptides (AMPs) have been emerged as
anti-cancer agents ((Baker et al. 1993; Bodek et al. 2005;
Cruciani et al. 1991; Makovitzki et al. 2009; Papo et al.
2006; Warren et al. 2001), for recent reviews see (Hoskin
and Ramamoorthy 2008; Schweizer 2009)).
AMPs, also termed host defense peptides, are wide-
spread in nature (Jenssen et al. 2006; Zasloff 2002). They
are gene-encoded peptides, which normally provide a first
line of defence against invading microbes on epithelial
tissues and are part of the armament of professional
immune cells. Examples are frog magainins (Zasloff
1987), cathelicidins (Larrick et al. 1995; Zanetti et al.
1995) and the human β–defensins (Harder et al. 1997;
Harder et al. 2001). In contrast to common antibiotics, most
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AMPs interact not specifically with a bacterial enzyme or
protein receptor, but directly with the lipid matrix of their
targets. This is achieved by an amphipathic secondary
structure of AMPs resulting in the segregation of hydro-
phobic and cationic surface areas of these molecules.
Interaction of AMPs with target cell membranes eventually
leads to the formation of lesions or pores and with that to a
disturbance or destruction of membrane potential and of the
membrane barrier function (Bechinger and Lohner 2006 ).
Killing by this mechanism is rapid and aggravates the
emergence of strains, which are resistant to these peptides.
Most AMPs target specifically bacteria and are almost non-
toxic for host cells. This differential sensitivity is driven by
electrostatic interactions with the negatively charged lipids
of the bacterial membranes (Hammer et al. 2010; Matsuzaki
et al. 1995; Schröder-Borm et al. 2003). Interestingly, it has
been shown that some cancer cells are killed by certain
AMPs, whereas primary cells, such as blood lymphocytes,
endothelial cells and fibroblasts were not affected by the
peptides (Chen et al. 2010; Cruciani et al. 1991; Hui et al.
2002; Johnstone et al. 2000; Schröder-Borm et al. 2005;
Tang et al. 2010).
There are several important advantages which endorse
the application of AMPs as anti-cancer drugs. Due to their
unique mode of action, they exhibit broad spectrum activity
and are generally not affected by resistance mechanism to
commonly used drugs (Johnstone et al. 2000; Kim et al.
2003; Wang et al. 2009). They can be easily added to a
conventional therapy and then act in synergy with chemo-
therapeutics and overcome resistance mechanism (Chuang
et al. 2008; Ohsaki et al. 1992; Papo et al. 2004). Moreover,
it may be speculated that they prevent growth of metastases
if given systemically and, as they are potent antimicrobials,
AMPs are likely to protect from bacterial infections during
or after surgery.
Up to now, the toxicity of peptides against cancer cells
has been documented in vitro using classical endpoint tests.
Cytotoxicity endpoint tests, such as the metabolic MTT test
or assays to detect the release (LDH) or uptake (PI) of
marker proteins and dyes, respectively, are suitable for
peptide screening and to give a first impression whether
membrane effects are involved in the peptides activities
(LDH and PI assay). As a disadvantage, they provide no
insights into the dynamics of the interplay between peptides
and cells. Since they are normally evaluated after a certain
time point (endpoint), they will overlook kinetics as well as
cell damages, which occur at an early time point and which
are repaired by the cells during incubation time. To close
this gap in the understanding of the mode of action of
AMPs as anti-cancer agents, we utilized a chip-based
analyzing system, which allows the continuous and label
free determination of cell metabolism and cell morphology
over time (Abarzua et al. 2010; Ceriotti et al. 2007;
Thedinga et al. 2007). Cells were grown on a chip surface,
which is equipped with pH, oxygen and impedance sensors.
Peptides diluted in medium are applied to the cells at a
defined flow rate. At regular time points, the flow is
stopped for a couple of minutes and the consumption of
oxygen, the change in pH, and the impedance of the cell
layer were simultaneously measured. Extracellular pH and
pO2 are mainly influenced by cellular glycolysis and
respiration, respectively. Both are measures of cell metab-
olism. The impedance of the cell layer is influenced by the
density and adhesion of the cell layer, the shape of the cells
and the contact zone between the cells and, hence, is a
sensitive measure of morphological changes within single
cells and the cell layer (Thedinga et al. 2007).
Using this chip-based sensor system, we investigated the
interactions of two representative AMPs and one inactive
variant thereof (Table 1) with two established human cell
lines. The peptides, i.e. melittin from bee venom (Dempsey
1990; Habermann and Jentsch 1967) and NK-2 (Andrä and
Leippe 1999), an internal fragment of porcine NK-lysin, are
well-characterized and exhibit pronounced antimicrobial
and anti-cancer cell activities (Andrä et al. 2007; Russell et
al. 2004; Schröder-Borm et al. 2005). Though NK-2 and
melittin are both cationic as well as similar in size and
structure, they are characterized by different degrees of
target selectivity and hydrophobicity. As target cells we
used the neuroblastoma cancer cell line LA-N-1 (Schröder-
Borm et al. 2005) and the spontaneously immortalized
non-cancer keratinocyte cell line HaCaT (Boukamp et al.
1988). LA-N-1 and HaCaT cells were of high and low
sensitivity to the action of the peptide NK-2, respectively
(Andrä and Leippe 1999; Schröder-Borm et al. 2005).
Moreover, we determined the hemolytic activity of
peptides, the binding of fluorescently-labelled peptides to
the cells and compared the biosensor data with classical
endpoint tests for cytotoxicity. To our knowledge, this is
the first report, in which the dynamic interplay of
membrane-interacting peptides and cancer cells in terms




Peptides were synthesized with an amidated C terminus by
the Fmoc solid-phase peptide synthesis technique on an
automatic peptide synthesizer (model 433 A; Applied
Biosystems) as described (Andrä et al. 2004). NBD-
labelled peptides were prepared as follows: Peptide coupled
to the resin and with protected side chains was suspended in
dimethylformamide, supplemented with trace amounts of
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pyridine. Then, a 4-fold molar excess of 4-chloro-7-nitro-
1,2,3-benzoxadiazole (NBD chloride, Fluka, Germany) was
added and the suspension was stirred gently overnight at
20 °C. The resin was filtered, washed and the peptide was
cleaved from the resin as described above. Purified and
lyophilized peptides were diluted 1 mM in 0.01% TFA and
stored at −20 °C until use.
Calculation of hydrophobicity values of peptides
All calculations were done using the Expasy proteomics
server (http://expasy.org). The GRAVY (Grand Average of
Hydropathy) value for a peptide or protein was calculated
as the sum of hydropathy values (Kyte and Doolittle 1982)
of all the amino acids, divided by the number of residues in
the sequence. Hydrophobicity plot was generated using the
consensus scale proposed by Eisenberg (Eisenberg et al.
1984) and a window size of 7.
Assay for hemolytic activity
Freshly isolated and washed human erythrocytes (5×108
cells/ml) in 20 μl PBS, pH 7.4, were incubated with 80 μl
of a peptide sample in the same buffer for 30 min at 37 °C
in a round bottom 96-well plate (Nunclon Surface, Nunc,
Roskilde, Denmark). After the incubation period the plate
was centrifuged at 1000×g for 10 min to remove intact
erythrocytes, and the concentration of released hemoglobin
was measured in a microtiter plate reader at 405 nm
(Rainbow, Tecan, Grödig/Salzburg, Austria) after ten-fold
dilution of the supernatant. Hemolytic activity was
expressed as percent hemolysis (% hemolysis=((ODSample-
ODbuffer)/(ODmax-ODbuffer)*100). Maximal lysis (ODmax)
was achieved by adding distilled water instead of the
peptide sample to the cells. Data shown represent the mean
of at least two experiments each performed in duplicate.
Culture and harvesting of human cell lines
Human cells used in this study were the keratinocyte cell
line HaCaT (Boukamp et al., 1988), and the neuroblastoma
cell line LA-N-1 (Schröder-Borm et al. 2005). Cells were
cultured in very low endotoxin (VLE)-RPMI 1640 (LA-N-
1) or DMEM (HaCaT), each supplemented with 10% heat-
inactivated FCS, L–glutamine, penicillin and streptomycin
at 37 °C in a humidified atmosphere at 5% CO2. Both
media were supplied from Biochrom (Berlin, Germany).
Cells were harvested by addition of 1 ml of trypsin/EDTA
in PBS (Biochrom) and incubation at 37 °C.
Preparation of 96-well plates for MTT and LDH assays
Freshly harvested cells were suspended in cell culture
medium with 10% FCS to a density of 2.5×105 cells/ml.
This suspension (100 μl) was filled in each well of a sterile
flat-bottom 96-well microtiter plate (Costar tissue culture
treated, Corning Incorporated, NY, USA). After incubation
at 37 °C in a humidified atmosphere with 5% CO2 for 24 h,
the medium was removed.
MTT assay
Metabolic activity, i.e. viability, of cells was determined in
96-well plates using the TOX-1 kit following the instruc-
tions of the manufacturer (SigmaAldrich, Steinheim, Ger-
many). Peptides, diluted from stock solutions in 0.01%
TFA into a mixture (v/v) of 10% standard cell culture
medium and 90% PBS, pH 7.4, were added to the wells
(100 μl each) of a 96-well plate to initially seeded 25.000
cells and were incubated for 4 h at 37 °C. As controls,
medium/PBS (MPBS=100% viability) and 5% triton X-100
in PBS (MT=0% viability) were added to wells loaded with
cells. For determination of cell viability, 10 μl of a solution
(5 mg/ml) of the tetrazolium salt 3-[4,5-dimethylthiazol-2-
yl]-2,5-diphenyltetrazolium bromide (MTT) in PBS, pH
7.4, was added to each well and incubated for 2 h at 37 °C.
Formed formazan crystals were dissolved by adding 10%
triton in acid isopropanol (100 μl) to each well, and the
extinction was measured using a microtiter-plate reader at
absorbance and reference wavelenghts of 570 and 690 nm,
respectively. Each experiment was performed in duplicates
and performed at least twice. Metabolic activity (%M) of
the cells was calculated using the following equation:
%M ¼ 100 MExp MT
 




Peptide-induced lysis of adherent cells was determined in
96-well plates using the Cytotoxicity Detection Kit based
on the release of lactate dehydrogenase (LDH) from lysed
cells following the instructions of the manufacturer (Roche,
Mannheim, Germany). Peptides, diluted from stock sol-
Peptide Source Sequence Net charge GRAVY
NK-2 Pig KILRG VCKKI MRTFL RRISK DILTG KK +10 −0.263
NK11 (NK-2) KISKR ILTGK K +6 −0.836
Melittin Honey bee GIGAV LKVLT TGLPA LISWI KRKRQ Q +6 +0.273
Table 1 Amino acid sequence,
net charge, hydrophobicity
(GRAVY, grand average of hy-
dropathy) of synthetic peptides
used in this study
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utions in 0.01% TFA into PBS, pH 7.4 or in Bionas running
medium (BRM, pH 7.4, see below), were added to the
wells (200 μl each) to initially seeded 25.000 cells and
were incubated for 4 h at 37 °C. As controls, PBS or BRM
(Lcontrol=0% lysis) and 5% triton X-100 in PBS or BRM
(LT=100% lysis) were added to wells loaded with cells.
After incubation, the plate was centrifuged and 100 μl of
the supernatants were transferred into another 96-well plate.
LDH reaction mixture (100 μl) was added, incubated in the
dark for 5 min at room temperature. The reaction was
stopped by adding 50 μl stop solution. Finally, the
extinction was measured using a microtiter-plate reader at
absorbance and reference wavelenghts of 490 nm and
630 nm, respectively. Each experiment was performed in
duplicates and repeated at least once. Cell lysis (%L) was
calculated using the following equation: %L ¼ 100
LExp  Lcontrol
 




Suspended cells with compromized membranes were
detected by monitoring the uptake of the DNA-
intercalating dye propidium iodide (PI) into the cells.
Freshly harvested cells (see above) were washed twice
with PBS, pH 7.4, and sedimented. Peptides (100 μl)
diluted in PBS were added to the cell pellet (2×105), the
cells were gently vortexed and incubated with the peptides
for 30 min at 37 °C. Then, PI (5 μl, 100 μg/ml, Invitrogen,
Eugene, Oregon, USA) was added and the suspension was
further incubated for 5 min at 4 °C in the dark. The reaction
mixtures were diluted in ice-cold buffer and analyzed with
a FACSCalibur (Becton Dickinson, Heidelberg, Germany)
flow cytometer with computer-assisted evaluation of data
(CellQuest software). Cell lysis (%L) was calculated from
the percentage of PI positive cells in buffer alone (PIcontrol)
and in the presence of peptides (PIexp): %L ¼ 100
PIexp  PIcontrol
 
= 100 PIcontrolð Þ
 
.
Binding of NBD-labelled peptides to cells
Freshly harvested cells (see above) were washed twice with
PBS, pH 7.4, and sedimented. NBD-labelled Peptides
(100 μl) diluted in PBS were added to the cell pellet (2×
105), the cells were gently vortexed and incubated with the
peptides for 30 min at 37 °C. These mixtures were diluted in
ice-cold buffer and analyzed with a FACSCalibur (Becton
Dickinson, Heidelberg, Germany) flow cytometer with
computer-assisted evaluation of data (CellQuest software).
Online monitoring of cell metabolism
For the online monitoring of three important cell physio-
logical parameters we used the Bionas analyzing system
15002 and 2500 (Bionas GmbH, Rostock, Germany). Cells
were grown adherently on a metabolic biosensor chip
(SC1000, Bionas) equipped with clark, ISFET, and IDES
sensors, which allow the simultaneous determination of
oxygen consumption, extracellular acidification and cell
impedance, respectively. Before each experiment the tube
system was disinfected with 70% ethanol and then rinsed
with PBS and conditioned with Bionas running medium
(BRM). BRM is a cell culture medium without bicarbonate
buffer but with 1 mM Hepes, pH 7.4, 4.5 g/l glucose, 0.1%
FCS, 100 U/ml penicillin and 100 μg/ml streptomycin
(Bionas GmbH, Rostock, Germany). Chips were also
disinfected with 70% ethanol, rinsed with PBS and then
conditioned with the respective standard cell culture
medium. Freshly harvested cells (2×105) were seeded on
the chips and cultivated in the respective standard medium
for 24 h at 37 °C and 5% CO2 in a humidified atmosphere.
After mounting the chips in the biomodules of the Bionas
system they were flushed with BRM. The system was
operated with low buffered running medium to allow the
assessment of changes in pH at a flow rate of 56 μl/min
with alternating “go” and “stop” phases of 4 min each.
During the “go” phase, cells on the chip are perfused with
fresh medium or medium with compound. In the subse-
quent “stop” phase, oxygen consumption and extracellular
acidification in the cell supernatant of each chip were
measured continuously. The change of the parameter, i.e.
the rate, is calculated for each “stop” phase and represents
the metabolic activity of the cells and is given as a single
data point in the figures. Cell impedance was monitored
during the whole run independently of the pump state and
its mean value is given as a single data point. One chip with
cells served as a control and was fed with running medium
without test compounds. Data are presented normalized to
untreated control cells in medium. Finally, the biomodules
were rinsed with 0.2% triton X-100 in BRM to achieve
complete cell lysis.
Results
Hydrophobicity analyses of peptides
The analysis of the hydrophobicity profiles of the peptides
revealed pronounced differences despite that they are all of a
similar length, charge and secondary structure (Fig. 1). The
profile of NK-2 is characterized by alternating hydrophilic
and hydrophobic amino acid residues reflecting the turns of
an α-helix, which indicates a highly amphipathic structure.
Melittin exhibited a completely different profile. The
sequence of this peptide is divided into a hydrophobic part
and a C-terminal hydrophilic part. In average, NK-2
appears hydrophilic and melittin hydrophobic (Table 1).
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Hemolytic activity of peptides
The hemolytic activity of peptides against freshly isolated
human erythrocytes was determined photometrically by
monitoring the release of hemoglobin (Fig. 2). The activity
correlated with the average hydrophobicity of the peptides
(Table 1): Melittin exhibited strong activity, NK-2 was
moderately hemolytic and NK11 was complete inactive.
Cytotoxicity tests
The direct toxicity of peptides against LA-N-1 and HaCaT
cells was analyzed by the use of three established assays
(Table 2):
i) The effect of the peptides on the metabolic activity of
cells was determined by the MTT assay (Fig. 3). By this
assay, the conversion of a tetrazolium salt (MTT) into
formazan by adherently growing cells was measured
after 4 h incubation in the presence of peptides in buffer
(PBS, pH 7.4) supplemented with 10% standard cell
culture medium to guarantee the metabolic efficacy of
the cells during the incubation period.
ii) The ability of the peptides to impair the membrane
integrity of adherently growing cells was investigated
by the LDH assay (Fig. 4). This assay is based on the
detection of the cytosolic enzyme LDH in the cell
culture supernatant after an incubation period of 4 h
with peptides. The LDH assay was performed in buffer
(PBS, pH 7.4) as well as in Bionas running medium
(BRM, pH 7.4) for a direct comparison of the LDH
assay results to the on-chip measurements (see below).
iii) Furthermore, we analyzed peptide-induced membrane
permeabilization of suspended cells by the uptake of
the DNA-intercalating fluorescent dye PI upon the
interaction with peptides in buffer for 30 min (Fig. 5).
Melittin and NK-2 exhibited potent anti-cancer cell
activities, whereas NK11 was completely inactive against
the two cell lines. For NK-2, we determined IC50 values of
3.6–20.2 μM and of 7.3–31.2 μM towards LA-N-1 and
HaCaT cells, respectively. Thus demonstrating a distinctive
selectivity between the cell lines. Melittin exhibited a
similar cell type dependency as NK-2. It was the most
active peptide in this group and its activity against the NB
cells was independent of the assay. Hence, the apparent
cytotoxic activity of a given peptide appeared to be strongly
dependent on the assay type and on the conditions the assay
was performed.
Binding of NBD-labelled peptides to the cancer cells
LA-N-1 and HaCaT cells were suspended by trypsination
and the binding of the fluorescently labelled peptides NBD-
NK-2 and NBD-NK11 was measured by flow cytometry.
As a prerequisite, we determined the effect of the NBD
Table 2 Comparison of the cytotoxicity of peptides against LA-N-1
NB and HaCaT cells using different types of endpoint tests. The
peptide concentration (IC50) which reduced the metabolic activity by
50% (MTT test) or which induced 50 % efflux (LDH assay) or influx
(PI uptake assay) are given in μM. The LDH test was performed in
buffer (PBS, pH 7.4) and in medium (BRM)
MTT LDH (PBS) LDH (BRM) PI
LA-N-1 NB cells
NK-2 3.6±0.4 11.4±1.6 20.2±3.3 12.0±1.6
NK11 >>100 >>100 >>100 >>100
Melittin 1.2±0.1 2.1±0.6 1.9±0.4 2.8±0.3
HaCaT cells
NK-2 7.3±0.8 10.9±0.2 31.2±5.2 26.8±0.6
NK11 >>100 >>100 >>100 >>100
Melittin 2.6±0.3 3.2±0.4 4.8±0.3 9.5±1.4
Fig. 2 Hemolytic activity of peptides. Lysis of human erythrocytes
was determined photometrically by measuring the release of hemo-
globin after incubation with peptides in PBS at 37 °C for 30 min. NK-
2, solid black circles; NK11, solid grey circles; melittin, open triangles
Fig. 1 Hydrophobicity plots of
peptides. Hydrophobicity values
were calculated using the
Eisenberg scale for hydropho-
bicity (Eisenberg et al. 1984).
NK-2, solid black; melittin,
dashed black curve
Fig. 3 Cytotoxic activity of peptides (I). Metabolic activity of (a) LA-
N-1 NB cells and of (b) HaCaT keratinocytes measured by the MTT
assay in PBS, pH 7.4, supplemented with 10% cell culture medium.
Cells were incubated in the buffer/medium mix as a control (open
circles) or with peptides (NK-2, black filled circles; NK11, grey filled
circles; and melittin, open triangles) at indicated concentrations for 4 h
at 37 °C
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modification on the cytotoxicity of the peptides by the
MTT test (Fig. 6): No influence of the NBD group was
detectable for NK-2. For NK11, the attachment of the NBD
group had a negligible effect on its cytotoxicity against LA-
N-1 cells, however, cytotoxicity considerably increased
against HaCaT cells (Fig. 6). The latter effect must be taken
under consideration when evaluating the binding of the
NBD modified peptides to the cells.
The two peptides clearly differ in their capability to bind to
the cancer cells. The measured green fluorescence of the cells,
as a marker of the amount of bound peptide, was considerably
higher for cells incubated with NBD-NK-2 than for cells
incubated with NBD-NK11 (Figs. 7 and 8). In the presence of
higher concentrations of NBD-NK11, two cell populations
emerge, which differ in both the amount of NBD-NK11
attached to the cells and the size of the cells (Fig. 7, panel C).
The binding of the peptide was enhanced to shrinked cells,
which most probably represent damaged cells. At first
glance, binding of peptides appeared to be very similar for
both cell types with a considerable increase of green
fluorescence, reflecting peptide binding to the cells, at
10 μM peptide concentration. It should be emphasized,
however, that minor binding of NBD-NK-2 to LA-N-1 cells
could be detected already at 1 μM NBD-NK-2.
Online monitoring of peptide-induced changes in cell
metabolism and morphology/adhesion
The impact of various concentrations of peptides to
adhesion/morphology and metabolic activity of LA-N-1
and HaCaT cells were monitored in real time and online by
the use of a chip-based sensor. Cells were grown adherently
on chips, which are equipped with impedance, pH and
oxygen sensors (see also Fig. 9a–c). If cells on the chip
were perfused with running medium, impedance and rates
for cell respiration (changes in O2 signal) and acidification
(changes in pH) were more or less constant for >20 h (not
shown). In the case that cells die, metabolic rates
(respiration and acidification) were reduced. Moreover,
impedance, i.e. the electric isolation of the chip surface by
the cells, decreased if cells rounded up, lost their tight
contact or got detached from the chip surface. Electrical
signals obtained for impedance had always a high quality,
whereas signals for pH and pO2 were more noisy. This
might explain some ups and downs in the curves.
Comparable to the standard cytotoxicity tests, melittin was
also most effective in the chip-based measurements. A
peptide concentration of 0.3 μM was sufficient to induce
killing of NB cells after perfusion for 6 h. Just before cells
died, they responded to the melittin treatment by an
enhanced acidification rate (i.e. glycolysis, Fig. 9c, arrows).
Interestingly, the kinetics of killing after this brief stress
response were very similar and rather independently of the
actual melittin concentration. HaCaT cells were less
sensitive than LA-N-1 cells to peptide treatment. The
changes in metabolism of HaCaT cells as a response to
Fig. 6 Influence of the fluorescent label NBD on the cytotoxicity of
peptides. Metabolic activity of (a) LA-N-1 NB cells and of (b) HaCaT
keratinocytes was measured by the MTT assay. Cells were incubated
with peptides (NK-2, black filled circles; NBD-NK-2, open black
circles; NK11, grey filled circles; NBD-NK11; open grey circles) at
indicated concentrations for 4 h at 37 °C
Fig. 5 Cytotoxic activity of peptides (III). Peptide-induced membrane
permeabilization was detected by PI uptake by (a) LA-N-1 NB cells
and by (b) HaCaT keratinocytes. Cells were incubated with peptides
(NK-2, black filled circles; NK11, grey filled circles; and melittin,
open triangles) in PBS, pH 7.4, for 30 min at 37 °C. Uptake of the
fluorescent dye PI by membrane-compromised cells was determined
by FACS analysis
Fig. 4 Cytotoxic activity of peptides (II). Membrane damage of (a, c)
LA-N-1 NB cells and (b, d) HaCaT keratinocytes measured by the
release of cytosolic enzyme LDH. Cells were incubated with indicated
amounts of peptides in PBS, pH 7.4 (upper panel), and in BRM (lower
panel) for 4 h at 37 °C. NK-2, black filled circles; NK11, grey filled
circles; melittin, open triangles; control, open circles
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peptides were more dramatic. Heterogeneous results were
observed for 1 μM melittin, which is apparently a threshold
concentration. In one set of experiments cells were initially
damaged, indicated by a slight decrease in impedance, than
cells recovered again (increase in impedance) while they
were continuously perfused with peptide-containing medium
(Fig. 9c, circle).
The selectivity of NK-2 for LA-N-1 over HaCaT cells
was underlined by the chip-based measurements (Fig. 9a).
Worth mentioning, both cell types responded rapidly to
NK-2 treatment by an increase in impedance, which is
enduring in case of sublethal concentrations of NK-2. Even
for peptide NK11 we could document a significant impact
on the cells (Fig. 9b), though it was absolutely non-toxic up
to 100 μM in the standard assays (see above). An increase
in impedance was obtained for NK11 treated LA-N-1 cells,
similar to the effect observed for NK-2. The delayed
increase after 13 h induced by 10 μM NK11, when
compared to a faster increase after 2 h for 30 μM NK11,
suggests that the peptide accumulated on the cell surface
until it reached a critical concentration sufficient to induce
changes in cell adhesion and/or morphology.
In addition to the on-chip electrical measurements, we
monitored the appearance of the cells on the chips by light
microscopy. Therefore, chips were removed from the
fluidic system during the stop phase, imaged and immedi-
ately replaced. This has been done representatively for NK-
2 (Fig. 10). Before the experiment, confluent cell layers
were observed for both cell types. After perfusion with NK-
2, LA-N-1 cells were rounded up and largely detached from
the surface. The layer of HaCaT cells appeared almost
unaltered by NK-2 (Fig. 10). Hence, NK-2 induced subtle
morphological changes of HaCaT cells detected by imped-
ance measurements were not visible by light microscopy at
this magnification.
Discussion
The aim of this study was to establish a chip-based sensor
to monitor the dynamic interplay of membrane-interacting
peptides with human cells. As a proof of principle, we
focussed on two established cell lines and three well-
characterized peptides. As the peptides are potential lead
structures for the development of anti-cancer drugs, it is of
utmost important to elucidate (i) their cytotoxicity against a
variety of cancer cells and normal cells, (ii) their detailed
mode of action, (iii) their killing kinetics and (iv) the
response of the target cells to peptide treatment. (i)
Cytotoxicity screening was performed using classical
endpoint tests, such as the MTT test, the LDH-release
assay and the PI-uptake assay. To address points (iii) to (iv)
we took advantage of cells cultivated on the chip surface of
a sensor connected with a perfusion system. This setup
enabled us to monitor the effects of the peptides on the
metabolism and cell morphology / adhesion in real time.
The differential cytotoxicity of peptide NK-2 against
human NB cancer cells and keratinocytes has been
established before (Andrä and Leippe 1999; Schröder-Borm
et al. 2005) and could be impressively also documented
here with the Bionas analyzing system. In fact, target cell
selectivity of NK-2 was even more clearly expressed
compared to the endpoint tests and documented superiority
of NK-2 over melittin regarding this issue. The slightly
improved binding of NK-2 to NB cells might contribute to
this selectivity (Fig. 8). With the classical cytotoxicity tests
we observed peptide-induced cell membrane damage within
30 min, and blockage of the residual metabolic activity,
thus killing of the cells, within 4 h. This killing kinetic is
extremely fast compared to other chemotherapeutic drugs
and will hamper the emergence of resistances against the
Fig. 8 Binding of NBD-labelled peptides to cells. FACS analysis of
(a) LA-N-1 NB cells and of (b) HaCaT keratinocytes after incubation
with indicated amounts of fluorescently-labelled peptides. NBD-NK-
2, filled black circles; NBD-NK11, open circles
Fig. 7 Binding of NBD-
labelled peptides to LA-N-1
NB cells. Cells were incubated
(a) in buffer alone, (b) with
30 μM NBD-NK-2, and (c) with
30 μM NBD-NK11 for 30 min
at 37 °C and were subsequently
analysed by flow cytometry
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Fig. 9 Online monitoring of cell metabolism and morphology/
adhesion by the use of a chip-based biosensor. Cells grown on a chip
were perfused with running medium which contained various amounts
of peptides (a) NK-2, (b) NK11, and (c) melittin; 0.3 μM (filled grey
diamonds), 1 μM (open circles), 3 μM (open triangles), 10 μM (open
squares), 30 μM (filled black circles). Respiration rate (oxygen
consumption), and acidification rate of the medium as well as cell
layer impedance are shown relative to untreated control cells. Cell
impedance values of “1.0” and “0” comply with a sensor chip covered
with cells, and no cells on a chip, respectively
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peptides. Moreover, the online-monitoring of the cells on
the sensor chip revealed an immediate response to the
peptides by morphological changes or by an modulated
metabolism. Killing was completed after 1–2 h for NK-2
and melittin. Preceding the cytotoxic effects of NK-2, we
observed an increase in cell impedance, which may be due
a closer cell-cell contact, an increase in cell adhesion or
flattening of the cell layer. This morphological effect of NK-2
was observed for both cell types and seemed to be
characteristic for the action of the peptide. It was not observed
for melittin indicating a different type of peptide-cell
interaction. Interestingly, also NK11, the inactive variant of
NK-2, led to a similar increase in impedance upon addition to
LA-N-1 cells. Such an increase in impedance has been
observed rarely and it has been shown that it is not associated
with cell damage, or an effect on the organization of the
cytoskeleton (Ceriotti et al. 2007; Thedinga et al. 2007),
which led to a decrease in impedance, but with
cycloheximide-mediated inhibition of protein biosynthesis
in HT-29 cells (Thedinga et al. 2007), suggesting intracellu-
lar structures as secondary targets for NK-2. Among the
three peptides, melittin was most effective. This confirmed
the high hemolytic activity and potent killing efficacy of
melittin that has been documented in many studies by us and
others before and is based on its high hydrophobicity (Andrä
and Leippe 1999; Blondelle and Houghten 1991; Leippe et
al. 1994; Schröder-Borm et al. 2005; Werkmeister et al.
1993). It is worth to mention that cell killing by melittin was
preceded by an enhanced cell metabolism, probably a stress
response to the peptide-induced cell damage.
Target selectivity is an important issue and from the
presented data it may be speculated, that selectivity is
connected with the hydrophobicity profile and the overall
hydrophobicity of the peptides. A nearly perfect amphi-
pathic secondary structure, which can be adapted by NK-2,
is the basis for selectivity.
From our data it can be concluded, that the tested peptides
accumulate on the cell surface until they reach a critical
concentration, which is necessary to result in cell response
and/or cell damage. This critical concentration can of course
also be reached for low-concentration solutions of peptides
due to the fact, that the cells are continuously perfused by
fresh peptide solution. The latter fact is an important
difference to classical cytotoxicity tests, where a constant
volume and thus a defined amount of the drug is incubated
with the cells. Such an effect is nicely observed for melittin. At
certain time points, LA-N-1 cells respond by a sharp and short
increase in acidification rate, then the cells underwent cell
death, which is evidenced by an decrease to zero for all three
measuring parameters. Even NK11, which was absolutely
non-cytotoxic up to 100 μM to both cell lines when analyzed
with the end-point tests, induced a significant increase in
impedance of LA-N-1 cells after long-term perfusion of the
cells with the peptide at a tenfold reduced concentration. This
characteristic of a perfusion-based analyzing system impedes
the definition of a clear-cut IC50, however, demonstrates on
the other hand that this system monitors extremely sensitive
any peptide-induced cell response. Other authors have
defined a dynamic IC50 after a defined perfusion time. i.e.
24 h (Thedinga et al. 2007).
In conclusion, with the chip-based sensor system we
were able to monitor the kinetics of killing, and could
reproduce cytotoxic properties of the peptides derived from
endpoint tests. IC50 values obtained from classical endpoint
tests are not necessarily comparable to dynamic IC50
values, which can be derived from the measuring curves
of the sensor system. However, the application of drugs to a
cell layer in a discontinuous perfusion system imitates an in
vivo situation much better than cytotoxicity tests in 96-well
plates and is, at least in our opinion, a clear advantage of
the sensor system. Moreover, we observed peptide-specific
metabolic and morphological responses of the cells as well
as cell recovery during treatment. Despite the fact, that both
peptides, NK-2 and melittin, interact with membranes and
induce membrane depolarization or lysis (Benachir and
Lafleur 1995; Schröder-Borm et al. 2003), our findings
suggest different modes of action, which would have been
overlooked by other cytotoxicity assays.
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Fig. 10 Light microscopy images of cell layers on biosensor chips.
Images of LA-N-1 NB cells (a;b) and of HaCaT keratinocytes (c, d)
were taken before (a, c) and after perfusion with 10 μM NK-2 for 18 h
(b) and with 30 μM NK-2 for 22 h (d), respectively. Sensors for pH
(FET), O2 (Clark) and interdigitated electrode structures (IDES) for
the measurement of impedance are indicated in (a)
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